Daniel Ysselstein, Ph.D.
bio image

Vice President, Biology

Dr. Ysselstein is the Director of Cell and Molecular Pharmacology at Vanqua. Prior to joining Vanqua, Dan worked at Northwestern University with Vanqua Co-Founder Dimitri Krainc. His work focused on using induced pluripotent stem cell-derived models to expand the understanding of basic CNS diseases including Parkinson’s and Frontal Temporal Dementia. Previously, Dan worked on alpha synuclein structural biology where he identified a new therapeutic approach to modulate alpha synuclein misfolding.